Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients
NCT03200184
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1448
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C
Interventions
DRUG:
sofosbuvir and daclatasvir
Sponsor
Tehran University of Medical Sciences